Accumulation of topical naproxen by cultured oral epithelium

Journal of Dental Research

Volumn 86, Issue 8, 2007, Pages 775-779

  Fitzgerald, R R ^a   Walters, J D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Analgesic; Inflammatory periodontitis

Indexed keywords

ALCOHOL; GLUCOSYLCERAMIDE; GLYCEROL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; POLOXAMER; SURFACTANT;

ACTIVE TRANSPORT; ARTICLE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; METABOLISM; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE, TUMOR; EPITHELIAL CELLS; ETHANOL; GLUCOSYLCERAMIDES; GLYCEROL; HUMANS; NAPROXEN; POLOXAMER; SURFACE-ACTIVE AGENTS;

EID: 34547941645     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600817     Document Type: Article

References (29)

1. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
2. Brayton JJ, Yang Q, Nakkula RJ, Walters JD (2002). An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells. J Periodontal 73:1267-1272.
3. Cavanaugh PF Jr, Meredith MP, Buchanan W, Doyle MJ, Reddy MS, Jeffcoat MK (1998). Coordinate production of PGE2 and IL-I beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse. J Periodontal Res 33:75-82.
4. Choi MJ, Maibach HI (2005). Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 6:215-223.
5. Coderch L, Lopez O, de la Maza A, Parra JL (2003). Ceramides and skin function. Am J Clin Dermatol 4:107-129.
6. Damiani P, Bearzotti M, Cabezon MA (2002). Spectrofluorometric determination of naproxen in tablets. J Pharm Biomed Anal 29:229-238.
7. Howell TH, Fiorellini J, Weber HP, Williams RC (1991). Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs. J Periodontal Res 26(3 Pt 1):180-183.Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA,
8. Williams DM (2001). Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis 7:349-354.
9. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P (1988). Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodontal Res 23:381-385.
10. Jeffcoat MK, Roddy MS, Haigh S, Buchanan W, Doyle MJ, Meredith MP, et al. (1995). A comparison of topical ketorolac, systemic flurbiprofen, and placebo for the inhibition of bone loss in adult periodontitis. J Periodontal 66:329-338.
11. Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I (2003). Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther 306:703-708.
12. Mullin JM, McGinn MT (1988). Effects of diacylglycerols on LLCPKl renal epithelia: similarity to phorbol ester tumor promoters. J Cell Physiol 134:357-366.
13. Oh TY, Ahn GJ. Choi SM, Ahn BO, Kim WB (2005). Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract. World J Gastroenterol 11:7450-7456.
14. Oringer RJ, Research, Science, and Therapy Committee of the American Academy of Periodontology (2002). Modulation of the host response in periodontal therapy. J Periodontal 73:460-470.
15. Paquette DW, Fiorellini JP, Martuscelli G, Oringer RJ, Howell TH, McCullough JR, et al. (1997). Enantiospecific inhibition of ligature-induced periodontitis in beagles with topical (S)kctoprofen. J Clin Periodontal 24:521-528.
16. Paquette DW, Lawrence HP, McCombs GB, Wilder R, Binder TA, Troullos E, et al. (2000). Pharmacodynamic effects of ketoprofen on crevicular fluid prostanoids in adult periodontitis. J Clin Periodontal 27:558-566.
17. Preshaw PM, Lauffart B, Brown P, Zak E, Heasman PA (1998). Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis. J Periodontal 69:777-783.
18. Rheinwald JG, Beckett MA (1981). Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41:1657-1663.
19. Sadecka J, Cakrt M, Hercegova A, Polonsky J, Skacani I (2001). Determination of ibuprofen and naproxen in tablets. J Pharm Biomed Anal 25:881-891.
20. Salvi GE, Lang NP (2005). Host response modulation in the management of periodontal diseases. J Clin Periodontal 32(Suppl 6):108-129.
21. Salvi GE, Williams RC, Offenbacher S (1997). Nonsteroidal antiinflammatory drugs as adjuncts in the management of periodontal diseases and peri-implantitis. Curr Opin Periodontal 4:51-58.
22. Siskind LJ, Kolesnick RN, Colombini M (2002). Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem 277:26796-26803.
23. Takagi Y, Nakagawa H, Yaginuma T, Takema Y, Imokawa G (2005). An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function. Arch Dermatol Res 297:18-25.
24. Takahashi A, Suzuki S, Kawasaki N, Kubo W, Miyazaki S, Loebenberg R, et al. (2002). Percutaneous absorption of nonsteroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats. Int J Pharm 246:179-186.
25. Tipton DA, Flynn JC, Stein SH, Dabbous M (2003). Cyclooxygenase2 inhibitors decrease interleukin-1 beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. J Periodontal 74:1754-1763.
26. Vavrova K, Hrabalek A, Dolezal P, Samalova L, Palat K, Zbytovska J, et al. (2003). Synthetic ceramide analogues as skin permeation enhancers: structure-activity relationships. Bioorg Med Chem 11:5381-5390.
27. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr (1999). Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129:1239-1250.
28. You G (2004). Towards an understanding of organic anion transporters: structure-function relationships. Med Res Rev 24:762-774.
29. Zavarella MM, Gbemi O, Walters JD (2006). Accumulation of nonsteroidal anti-inflammatory drugs by gingival fibroblasts. J Dent Res 85:452-456.